CasLoc logo
All Cases PTAB Litigations UPC Oppositions

Novartis Pharmaceuticals Corporation v. Par Pharmaceutical Inc.

1:15-cv-01050

Overview

Case Number 1:15-cv-01050
Filing Date 2015-11-13
Status Terminated
Termination Date 2018-01-08
Court District Court, D. Delaware (ded)
Nature of Suit 830 Patent
Jurisdiction Type Federal Question
Cause of Action 35:271 Patent Infringement
Jury Demand None

Parties

Defendant

Par Pharmaceutical Inc. Operating Company

Represented By

7 Attorneys Listed

Steven J. Fineman

Richards, Layton & Finger, PA

Tel: +1 (302) 658-6541

Richards, Layton & Finger, PA, One Rodney Square

Parker M. Tresemer

UNDELIVERABLE EMAIL 2/12/2019

Marc N. Zubick

Email: marc.zubick@lw.com

Katharine Lester Mowery

Richards, Layton & Finger, PA

Tel: +1 (302) 651-7623

Richards, Layton & Finger, PA, One Rodney Square

Emily Sauter

UNDELIVERABLE EMAIL 2/12/2019

Brenda L. Danek

Email: brenda.danek@lw.com

Sarah W. Wang

Email: Sarah.Wang@lw.com

Plaintiff

Novartis Pharmaceuticals Corporation Operating Company

Represented By

5 Attorneys Listed

Nicholas N. Kallas

Email: nkallas@venable.com

Daniel M. Silver

McCarter & English, LLP

Tel: +1 (302) 984-6300
Fax: +1 (302) 691-1260

Renaissance Centre, 405 N. King Street, 8th Floor

Christina Schwarz

Email: cschwarz@venable.com

Benjamin A. Smyth

McCarter & English, LLP

Tel: +1 (302) 984-6300

Renaissance Centre, 405 N. King Street, 8th Floor

Michael P. Kelly

McCarter & English, LLP

Tel: +1 (302) 984-6300
Fax: +1 (302) 984-6399

Renaissance Centre, 405 N. King Street, 8th Floor

Court & Judges

Court

District Court, D. Delaware (ded)

Global Patent Family Cross-Litigation Radar

CasLoc 360Β° Radar 5 Family Members

Multi-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions

πŸ‡ΊπŸ‡Έ
U.S. District Courts 1 proceeding
πŸ›οΈ
USPTO PTAB Trials 2 proceedings
πŸ‡ͺπŸ‡Ί
Unified Patent Court (UPC) Counterparts in force
πŸ‡©πŸ‡ͺ
European Patent Office (EPO) Counterparts in force
Worldwide Family Members (5): GB πŸ‡ΊπŸ‡Έ US 🌐 PCT
Parallel Proceedings Across Jurisdictions (3 found):
PTAB: 2 U.S. Courts: 1
USPTO PTAB Trial 2018-01-17
IPR2018-00507

Hikma Pharmaceuticals PLC v. Novartis Pharmaceuticals Corporation

U.S. Continuation Sibling (8410131)
Status: Terminated-Settled
USPTO PTAB Trial 2017-06-12
IPR2017-01592

Breckenridge Pharmaceutial, Inc. v. Novartis Pharmaceuticals Corporation

U.S. Continuation Sibling (8410131)
Status: Terminated-Settled
U.S. District Court 2017-04-07
1:17-cv-00393

Novartis Pharmaceuticals Corporation v. Teva Pharmaceuticals USA, Inc.

Asserted Patent
Status: DED
Stay ahead of cross-border rulings. Subscribe for free automated docket alerts across U.S. Courts, PTAB, UPC, and EPO.

Patents Involved

2 Patents

There are 2 patents involved in this case.

Patent Asset Filing & Issue Date Expiration & Term Status External Links
US8436010
Treatment of solid tumors with rapamycin derivatives
Filed: 2012-02-23
Issued: 2013-05-07
Expired (Term Ended)
Expires: 2022-02-22
US836010
Protective cover for picture-frames.
Filed: 1906-01-06
Issued: 1906-11-13
Expired (Term Ended)
Expires: 1926-01-06

Patent Enforceability & Injunction Risk Assessment

Statutory Analysis
Injunction Viability (35 U.S.C. Β§ 283) Statutorily Barred

Statutorily Barred β€” Patent expired. Under 35 U.S.C. Β§ 283, injunctive relief is barred.

Terminal Disclaimer & Cellect Risk Low Risk

Standard Statutory Term β€” No obviousness-type double patenting noted.

Damages Lookback Horizon 6-Yr Max Lookback

Under 35 U.S.C. Β§ 286, damages cannot accrue for infringement prior to 6 years before filing. 4th & 8th Year Maintenance Fees Paid (12th Year Window Upcoming).

Procedural Motions & Interlocutory Orders

Motion Intelligence

Total Motions

3

Dispositive

0

Granted

0

Denied

0

Pending / Review

3

Motions by Category

Claim Construction / Markman Filing 3

Key Dispositive Motions & Rulings

Claim Construction / Markman Filing Pending / Under Review
ORAL ORDER: The Markman Hearing scheduled for 3/28/2017, is now CANCELED (see letter at D.I. 32 ). Ordered by Judge Richard G. Andrews on 12/22/2016. (nms) (Ent...
Entry #33 • 2016-12-22 Document →
Claim Construction / Markman Filing Pending / Under Review
Letter to The Honorable Richard G. Andrews from Daniel M. Silver, Esq. regarding Markman Hearing. (Silver, Daniel) (Entered: 12/21/2016)
Entry #32 • 2016-12-21 Document →
Claim Construction / Markman Filing Pending / Under Review
SCHEDULING ORDER: Case referred to the Magistrate Judge for the purpose of exploring ADR. Joinder of Parties due by 8/31/2016. Amended Pleadings due by 8/31/201...
Entry #16 • 2016-01-07 Document →

Docket Entries

(99 total)
Pleading / Complaint

COMPLAINT for PATENT INFRINGEMENT filed against Par Pharmaceutical Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-1827359.) - filed by Novartis Pharmaceuticals Corporation. (Attachments: # 1 Exhibit A, # 2 Civil Cover Sheet)(nmb) (Entered: 11/13/2015)

Entry #1 • 2015-11-13
1
Pleading / Complaint

COMPLAINT for PATENT INFRINGEMENT filed against Par Pharmaceutical Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-1827359.) - filed by Novartis Pharmaceuticals Corporation. (Attachments: # 1 Exhibit A, # 2 Civil Cover Sheet)(nmb) (Entered: 11/13/2015)

Entry #1 • 2015-11-13
2
Pleading / Complaint

COMPLAINT for PATENT INFRINGEMENT filed against Par Pharmaceutical Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-1827359.) - filed by Novartis Pharmaceuticals Corporation. (Attachments: # 1 Exhibit A, # 2 Civil Cover Sheet)(nmb) (Entered: 11/13/2015)

Entry #1 • 2015-11-13
2

Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (nmb) (Entered: 11/13/2015)

Entry #2 • 2015-11-13
1

Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 10/1/2015. Date of Expiration of Patent: 2/22/2022.Thirty Month Stay Deadline: 4/1/2018. (nmb) (Entered: 11/13/2015)

Entry #3 • 2015-11-13
1

Track Case Updates

Automated email notifications for new filings & decisions

Identifier: •

Free service • 1-click unsubscribe anytime • Powered by CasLoc